Trends in Urology & Men's Health
Trends in Urology & Men's Health is a journal for healthcare professionals providing high-quality articles in the areas of prostate disease, erectile dysfunction, incontinence and genitourinary medicine. It also covers other areas that affect men's health, including cardiovascular disease and diabetes.
The Trends in Urology & Men’s Health website provides up-to-date news, videos, useful tools, leaflets for your patients, website links and diary dates - as well as the current and past issues of the journal. Access to all content is free to healthcare professionals following registration.
Listen to a new podcast by Alan White, who reviews the State of Men’s Health in Europe report.
Trends in Urology & Men's Health is published in collaboration with BJU International.
Current Issue
- Charity begins at home
- Published online on Jan 23, 2012
- Overactive bladder in men: initial assessment
- Published online on Jan 23, 2012
- Thromboprophylaxis after surgery
- Published online on Jan 23, 2012
- Current issues in men's health
- Published online on Jan 23, 2012
- Barrett's oesophagus: raising awareness in heartburn sufferers
- Published online on Jan 23, 2012
- Relevance of the quality standard for chronic kidney disease to GPs
- Published online on Jan 23, 2012
- Setting priorities for prostate cancer research
- Published online on Jan 23, 2012
- Reducing harm in healthcare through understanding the ‘human factor’
- Published online on Jan 23, 2012
- Supporting the supporter: helping the partner of patients newly diagnosed with prostate cancer
- Published online on Jan 23, 2012
- Better health for men
- Published online on Jan 23, 2012
- Men's Health Forum
- Published online on Jan 23, 2012
- Update on the latest BJU International articles
- Published online on Jan 23, 2012
Ask Trends
For healthcare professionals only
Do you have a question that you would like our specialists to answer? Click here to send us your query.
Latest News
- MDV3100 increases prostate cancer survival after docetaxel
- Published on Feb 21, 2012
MDV3100, the novel oral androgen-receptor signalling inhibitor developed by Astellas and Medivation, increased overall survival by 4.8 months (18.4...
- Critical response to ‘adjunctive’ dutasteride
- Published on Feb 21, 2012
A trial published in the Lancet suggesting that dutasteride could be a useful adjunct to active surveillance in men with low-risk prostate cancer has...
- NICE may decline abiraterone
- Published on Feb 21, 2012
NICE is not minded to recommend abiraterone (Zytiga) for, in combination with prednisolone, castration-resistant metastatic prostate cancer after...
Patient information and resources
Click here to select and print out information for your patients on the following topics:
- Arthritis
- Cancer
- Cardiology
- Dementia
- Diabetes
- Lung disease
- Obesity
- Parkinson's disease
- Sexual health
- Stopping smoking
- Stroke
Login/Logout
Journal Menu
- Home
- What is Trends?
- News & Notes
- Current Issue
- Archive Issues
- Ask Trends
- Patient Resources
- Diagnostic Tools
- Useful Websites
- Diary Dates
- Videos
- Podcasts
.gif)






